Core Points - The meeting between the head of China's National Medical Products Administration and the head of Indonesia's Food and Drug Authority focused on enhancing cooperation in drug regulation and clinical trials [1] - Both parties agreed to deepen regulatory exchanges and collaboration to promote the launch of high-quality pharmaceutical products benefiting the citizens of both countries [1] Group 1 - The discussion included topics such as multi-center clinical trials, production facility supervision, information technology development, and smart regulation [1] - The meeting signifies a commitment to improving drug regulatory frameworks and ensuring the safety and efficacy of medical products [1]